Shenzhen Bioeasy Shares Outstanding vs. Return On Equity

300942 Stock   9.58  0.34  3.43%   
Based on the key profitability measurements obtained from Shenzhen Bioeasy's financial statements, Shenzhen Bioeasy Biotechnology may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in January. Profitability indicators assess Shenzhen Bioeasy's ability to earn profits and add value for shareholders.
For Shenzhen Bioeasy profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Shenzhen Bioeasy to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Shenzhen Bioeasy Biotechnology utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Shenzhen Bioeasy's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Shenzhen Bioeasy Biotechnology over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Shenzhen Bioeasy's value and its price as these two are different measures arrived at by different means. Investors typically determine if Shenzhen Bioeasy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Shenzhen Bioeasy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Shenzhen Bioeasy Bio Return On Equity vs. Shares Outstanding Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Shenzhen Bioeasy's current stock value. Our valuation model uses many indicators to compare Shenzhen Bioeasy value to that of its competitors to determine the firm's financial worth.
Shenzhen Bioeasy Biotechnology is number one stock in shares outstanding category among its peers. It also is number one stock in return on equity category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Shenzhen Bioeasy by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Shenzhen Bioeasy's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Shenzhen Return On Equity vs. Shares Outstanding

Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shenzhen Bioeasy

Shares Outstanding

 = 

Public Shares

-

Repurchased

 = 
400.87 M
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Shenzhen Bioeasy

Return On Equity

 = 

Net Income

Total Equity

 = 
-0.0919
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.

Shenzhen Return On Equity Comparison

Shenzhen Bioeasy is currently under evaluation in return on equity category among its peers.

Shenzhen Bioeasy Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Shenzhen Bioeasy, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Shenzhen Bioeasy will eventually generate negative long term returns. The profitability progress is the general direction of Shenzhen Bioeasy's change in net profit over the period of time. It can combine multiple indicators of Shenzhen Bioeasy, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Operating Income-66.9 M-63.5 M
Income Before Tax-177.8 M-168.9 M
Net Income Applicable To Common Shares272 M285.6 M
Net Loss-184.9 M-175.7 M
Net Interest Income-3.2 M-3.1 M
Interest Income7.6 M7.9 M
Net Loss-185 M-175.7 M

Shenzhen Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Shenzhen Bioeasy. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Shenzhen Bioeasy position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Shenzhen Bioeasy's important profitability drivers and their relationship over time.

Use Shenzhen Bioeasy in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Shenzhen Bioeasy position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shenzhen Bioeasy will appreciate offsetting losses from the drop in the long position's value.

Shenzhen Bioeasy Pair Trading

Shenzhen Bioeasy Biotechnology Pair Trading Analysis

The ability to find closely correlated positions to Shenzhen Bioeasy could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Shenzhen Bioeasy when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Shenzhen Bioeasy - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Shenzhen Bioeasy Biotechnology to buy it.
The correlation of Shenzhen Bioeasy is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Shenzhen Bioeasy moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Shenzhen Bioeasy Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Shenzhen Bioeasy can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Shenzhen Bioeasy position

In addition to having Shenzhen Bioeasy in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Exotic Funds Thematic Idea Now

Exotic Funds
Exotic Funds Theme
Funds or Etfs with high minimum investment requirement that manage portfolios of alternative investments such as hedge funds, options, futures, real estate or commodities. The Exotic Funds theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Exotic Funds Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Shenzhen Stock

To fully project Shenzhen Bioeasy's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Shenzhen Bioeasy Bio at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Shenzhen Bioeasy's income statement, its balance sheet, and the statement of cash flows.
Potential Shenzhen Bioeasy investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Shenzhen Bioeasy investors may work on each financial statement separately, they are all related. The changes in Shenzhen Bioeasy's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Shenzhen Bioeasy's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.